| II-20 Thomas Bouillon Comparison and selection of dosing regimens by discretization, optimizing efficacy and evaluating exposure demonstrated for KAE609 (Cipargamin) Wednesday 15:35-17:00 |
| II-20 Thomas Bouillon Comparison and selection of dosing regimens by discretization, optimizing efficacy and evaluating exposure demonstrated for KAE609 (Cipargamin) Wednesday 15:35-17:00 |